New and updated respiratory syncytial virus (RSV) resources

August 13, 2025

The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.

A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).

  • Arexvy® must not be administered to pregnant women.
  • Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
  • Abrysvo® and Arexvy® must not be administered to infants or children.
  • The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.

Updated resources include:

For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing

Latest news

November 16, 2026
With an increased number of Victorians travelling overseas during holiday periods, healthcare professionals play a vital role in ensuring that patients are prepared to stay safe and protected from infections before, during and after travelling.
November 10, 2026
Do you know a First Nations carer supporting a loved one experiencing challenges related to alcohol and other drugs, or mental health? Delivered by Windana and funded by SEMPHN, the First Peoples’ Carers Program is a free group program that offers an opportunity to connect with others in a safe, culturally supportive environment.
November 9, 2026
New statewide referral criteria for 7 children’s medicine conditions come into effect from 1 December 2026 in all Victorian public hospitals.